Spinal Manipulation Offers Little Low Back Pain Disability Relief

This article originally appeared here.
Share this content:
Spinal Manipulation Offers Little Low Back Pain Disability Relief
Spinal Manipulation Offers Little Low Back Pain Disability Relief

WEDNESDAY, April 20, 2016 (HealthDay News) -- Spinal manipulative therapy reduces disability from low back pain (LBP) more than functional technique, but not in a clinically meaningful way, according to a study published in the March issue of The Spine Journal.

Adelaida María Castro-Sánchez, P.T., Ph.D., from the University of Almeria in Spain, and colleagues compared the effective of spinal manipulation or functional technique (three once-weekly sessions) on pain, disability, kinesiophobia, and quality of life in 62 patients with chronic LBP.

The researchers found that patients receiving spinal manipulation experienced statistically, although not clinically, significant greater reductions in terms of disability. Over time, both groups showed significant improvement for the Roland-Morris Disability Questionnaire (both groups P < 0.001) and Oswestry Low Back Pain Disability Index (both groups P < 0.001). However, for pain intensity (P = 0.488), Tampa Scale of Kinesiophobia (P = 0.552), any domains of the Short Form-36 quality-of-life questionnaire (P ≤ 0.164), isometric resistance of abdominal muscles (P = 0.512), and finger-to-floor distance (P = 0.194), there were no significant treatment-by-time interactions.

"As neither group met the threshold for minimum clinically important difference following treatment, neither treatment resulted in a clinically meaningful benefit," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »